Genius Group launches Bitcoin Treasury with purchase of 110 Bitcoin for $10 million
SINGAPORE, Nov. 18, 2024 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading […]
Beyond Oil Secures C$1.77 Million in Funding Through Warrant Exercises, Led by Strategic Partner West Coast Reduction
VANCOUVER, B.C. and KIBBUTZ YIFAT, ISRAEL , Nov. 18, 2024 (GLOBE NEWSWIRE) — Beyond Oil Ltd. (CSE: BOIL) (OTCQB: BEOLF) […]
Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements
Two patients exceed 14 months on treatment in Phase 2 trialof advanced ovarian cancer Allarity maintains a cash balance of […]
Sharps Regains Nasdaq Listing Compliance
NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and […]
Galectin Therapeutics Presents Three Abstracts at the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting
Patient population for the NAVIGATE trial is based on non-invasive tests and clinical criteria utilizing latest treatment guidelines for portal […]
VIVOPOWER’S TEMBO SECURES FULL ON ROAD HOMOLOGATION FOR ITS TEMBO TUSKER 100% ELECTRIC VEHICLES IN US$10 bn AUSTRALASIAN PICK UP TRUCK MARKET
Tembo Tusker is only the 2ndfull electric utility vehicle pick up truck to receive full on road homologation VTA regulatory […]
TSX News -
Goodfellow Inc. Renews Its Normal Course Issuer Bid
DELSON, Quebec, Nov. 18, 2024 (GLOBE NEWSWIRE) — Goodfellow Inc. (TSX: GDL) (“Goodfellow” or the “Company”), announced today that the […]
Tornado Global Hydrovacs Reports Third Quarter 2024 Results
CALGARY, Alberta, Nov. 18, 2024 (GLOBE NEWSWIRE) — Tornado Global Hydrovacs Ltd. (“Tornado” or the “Company”) (TSX-V: TGH; OTCQX: TGHLF) […]
Eminent Gold Commences Drilling on Getchell Trend Analogue in Nevada
VANCOUVER, British Columbia, Nov. 18, 2024 (GLOBE NEWSWIRE) — Eminent Gold Corp. (TSX-V: EMNT) (OTCQB: EMGDF) (the “Company” or “Eminent”) […]
Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
TORONTO and PHILADELPHIA, Nov. 18, 2024 (GLOBE NEWSWIRE) — Medicus Pharma Ltd (NASDAQ: MDCX TSXV: MDCX) (the “Company”) is pleased […]
